Certara
CERT
8.96
-0.31
-3.34%
Certara
US · CERT
#2994 by market cap
Listed 2020
8.96
-0.31
-3.34%
Live - 5344 symbols - heartbeat 158s ago
· 2026-10-08 07:01
Pre-market
8.95
-0.11%
After-hours
8.92
-0.40%
Overnight
9.10
+1.56%
- Market cap
- 1.37B
- P/E (TTM)i
- -20.36
- P/Bi
- 1.41
- EPSi
- -0.01
- Div yieldi
- 0.00%
- 52W posi
- 53%
Reader sentiment
Are you bullish or bearish on CERT?
Anonymous reader poll. Unscientific, not investment advice.
About Certara
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Radnor, PA.
- Founded
- 2017
- CEO
- Mr. Jon Resnick
- Employees
- 1,576
- Headquarters
- Radnor, Pennsylvania, United States of America
- Fiscal year end
- 12-31
- Website
- certara.com
Company profile
- Exchange
- US
- Symbol
- CERT
- Market-cap rank
- #2994
- Listing date
- 2020-12-11
- Market cap
- 1.37B
- Float cap
- 1.00B
- Shares out
- 152.54M
- Float shares
- 111.95M
Sectors & themes
Health Information Services
Fractional Shares JP
Quote time 2026-10-08 07:01:30 · For reference only, not investment advice and not tailored to your situation.